Kobayashi Pharmaceutical Co., Ltd. logo

Kobayashi Pharmaceutical Co., Ltd.

4967.T

JPXConsumer DefensiveHousehold & Personal Products

Latest quote

¥5,642

+¥8.00 · +0.14%

Aug 24, 1:21 PM JST

4967.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.

Industry
Household & Personal Products
Sector
Consumer Defensive
Headquarters
JP
CEO
Norikazu Toyoda
Listed since
Jan 4, 2001
Employees
3,731

Market position

Day range

Current ¥5,642

52-week range

Current ¥5,642

Open
¥5,635
Previous close
¥5,634
Volume
57.8K
0.25× average
Average volume
229.23K
Average daily volume
Market cap
419.42B JPY
Beta
0.27
Market reference 1
50-day average
¥5,534.04
+1.95% above average
200-day average
¥5,573.87
+1.22% above average

Earnings

EPS beat rate
27%
3 beats, 8 misses, 0 met estimates
Average EPS surprise
-31.86%
11 comparable reports
Latest EPS result
1.3
Estimate 23.55 · Miss by 94.48%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates91.7443.71-4.32-52.35Q1 '25MissQ2 '25MissQ3 '25MissQ4 '25BeatQ1 '26MissQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 7, 2025: actual 63.53, estimate 78.13, surprise -18.69%, Miss. Q2 2025, reported May 8, 2025: actual 21.86, estimate 50.02, surprise -56.30%, Miss. Q3 2025, reported Aug 5, 2025: actual 20.75, estimate 24.03, surprise -13.65%, Miss. Q4 2025, reported Nov 11, 2025: actual 48.99, estimate 43.93, surprise +11.52%, Beat. Q1 2026, reported Feb 10, 2026: actual -42.41, estimate 81.8, surprise -151.85%, Miss. Q2 2026, reported May 8, 2026: actual 13.95, estimate 5.38, surprise +159.29%, Beat. Q3 2026, reported Aug 6, 2026: actual 1.3, estimate 23.55, surprise -94.48%, Miss. Q4 2026, reported Nov 5, 2026: actual —, estimate 48.43, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates55.85B47.32B38.79B30.25BQ1 '25BeatQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26BeatQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 7, 2025: actual 51.14B JPY, estimate 32.4B JPY, surprise +57.84%, Beat. Q2 2025, reported May 8, 2025: actual 32.61B JPY, estimate 37.97B JPY, surprise -14.13%, Miss. Q3 2025, reported Aug 5, 2025: actual 36.41B JPY, estimate 38.42B JPY, surprise -5.22%, Miss. Q4 2025, reported Nov 11, 2025: actual 43.02B JPY, estimate 43.44B JPY, surprise -0.98%, Miss. Q1 2026, reported Feb 10, 2026: actual 53.7B JPY, estimate 53.38B JPY, surprise +0.61%, Beat. Q2 2026, reported May 8, 2026: actual 33.67B JPY, estimate 33.74B JPY, surprise -0.21%, Miss. Q3 2026, reported Aug 6, 2026: actual 37.08B JPY, estimate 37.44B JPY, surprise -0.95%, Miss. Q4 2026, reported Nov 5, 2026: actual —, estimate 45.4B JPY, surprise —, Comparison unavailable.

Corporate actions

Corporate action history

Stock split

Effective Jun 28, 2016

2:1

Stock split

Effective Sep 25, 2003

3:2

4967.T peers

ETFs holding 4967.T

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 4967.T

research.disclaimer